Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 32 Records) |
| Query Trace: Disease Progression and BRCA2[original query] |
|---|
| Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients. PloS one 2016 11 (6): e0156789. Zhong Xiaorong, Dong Zhengwei, Dong Hua, Li Jiayuan, Peng Zuxiang, Deng Ling, Zhu Xuehua, Sun Yun, Lu Xuesong, Shen Fuxiao, Su Xinying, Zhang Liying, Gu Yi, Zheng Ho |
| Characterizing key nucleotide polymorphisms of hepatitis C virus-disease associations via mass-spectrometric genotyping. International journal of oncology 2017 12 52 (2): 441-452. Horiuchi Yuta, Lin Jason, Shinojima Yui, Fujiwara Kyoko, Moriyama Mitsuhiko, Nagase Hiro |
| Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma. European journal of cancer (Oxford, England : 1990) 2017 12 89 19-26. Lowery Maeve A, Kelsen David P, Capanu Marinela, Smith Sloane C, Lee Jonathan W, Stadler Zsofia K, Moore Malcolm J, Kindler Hedy L, Golan Talia, Segal Amiel, Maynard Hannah, Hollywood Ellen, Moynahan MaryEllen, Salo-Mullen Erin E, Do Richard Kinh Gian, Chen Alice P, Yu Kenneth H, Tang Laura H, O'Reilly Eileen |
| Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer. The New England journal of medicine 2018 10 379 (26): 2495-2505. Moore Kathleen, Colombo Nicoletta, Scambia Giovanni, Kim Byoung-Gie, Oaknin Ana, Friedlander Michael, Lisyanskaya Alla, Floquet Anne, Leary Alexandra, Sonke Gabe S, Gourley Charlie, Banerjee Susana, Oza Amit, González-Martín Antonio, Aghajanian Carol, Bradley William, Mathews Cara, Liu Joyce, Lowe Elizabeth S, Bloomfield Ralph, DiSilvestro Pa |
| A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer. Investigational new drugs 2018 1 36 (5): 828-835. van der Biessen Diane A J, Gietema Jourik A, de Jonge Maja J A, Desar Ingrid M E, den Hollander Martha W, Dudley Matthew, Dunbar Martin, Hetman Robert, Serpenti Camille, Xiong Hao, Mittapalli Rajendar K, Timms Kirsten M, Ansell Peter, Ratajczak Christine K, Shepherd Stacie Peacock, van Herpen Carla M |
| Olaparib maintenance monotherapy in platinum-sensitive, relapsed ovarian cancer without germline BRCA mutations: OPINION Phase IIIb study design. Future oncology (London, England) 2019 9 15 (32): 3651-3663. Poveda Andres M, Davidson Richard, Blakeley Christopher, Milner Alv |
| Prevalence and clinical outcomes of germline mutations in BRCA1/2 and PALB2 genes in 2769 unselected breast cancer patients in China. International journal of cancer 2019 Feb . Deng Mei, Chen Hui-Hui, Zhu Xuan, Luo Meng, Zhang Kun, Xu Chun-Jing, Hu Kai-Min, Cheng Pu, Zhou Jiao-Jiao, Zheng Shu, Chen Yi-Di |
| Longitudinal analysis of a secondary BRCA2 mutation using digital droplet PCR. The journal of pathology. Clinical research 2019 10 6 (1): 3-11. Khalique Saira, Pettitt Stephen J, Kelly Ger, Tunariu Nina, Natrajan Rachael, Banerjee Susana, Lord Christopher |
| Efficacy of Maintenance Olaparib for Patients With Newly Diagnosed Advanced Ovarian Cancer With a BRCA Mutation: Subgroup Analysis Findings From the SOLO1 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020 8 38 (30): 3528-3537. DiSilvestro Paul, Colombo Nicoletta, Scambia Giovanni, Kim Byoung-Gie, Oaknin Ana, Friedlander Michael, Lisyanskaya Alla, Floquet Anne, Leary Alexandra, Sonke Gabe S, Gourley Charlie, Banerjee Susana, Oza Amit, González-Martín Antonio, Aghajanian Carol A, Bradley William H, Mathews Cara A, Liu Joyce, Lowe Elizabeth S, Bloomfield Ralph, Moore Kathleen |
| Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet. Oncology 2020 8 21 (10): 1269-1282. Diéras Véronique, Han Hyo S, Kaufman Bella, Wildiers Hans, Friedlander Michael, Ayoub Jean-Pierre, Puhalla Shannon L, Bondarenko Igor, Campone Mario, Jakobsen Erik H, Jalving Mathilde, Oprean Cristina, Palácová Marketa, Park Yeon Hee, Shparyk Yaroslav, Yañez Eduardo, Khandelwal Nikhil, Kundu Madan G, Dudley Matthew, Ratajczak Christine K, Maag David, Arun Banu |
| Outcomes and risk of subsequent breast events in breast-conserving surgery patients with BRCA1 and BRCA2 mutation. Cancer medicine 2020 Jan . Ye Fugui, Huang Liang, Lang Guantian, Hu Xin, Di Genhong, Shao Zhimin, Cao Ayo |
| Metastatic Castration-Resistant Prostate Cancer Remains Dependent on Oncogenic Drivers Found in Primary Tumors. JCO precision oncology 2021 9 5 . Einstein David J, Arai Seiji, Calagua Carla, Xie Fang, Voznesensky Olga, Capaldo Brian J, Luffman Christina, Hecht Jonathan L, Balk Steven P, Sowalsky Adam G, Russo Joshua |
| A novel germline BRCA2 mutation in a Chinese patient with prostate cancer sensitive to platinum chemotherapy: a case report. BMC urology 2021 8 21 (1): 114. Jiang Lijuan, Bai Zunguang, Zhu Shoulun, Zhao Tingting, Yang Yining, Li Zhiyong, Chen Dong, Wu Zhiming, Wang Yanjun, Zhou Fangjian, Li Yongho |
| Unique evolutionary trajectories of breast cancers with distinct genomic and spatial heterogeneity. Scientific reports 2021 5 11 (1): 10571. Phung Tanya N, Webster Timothy H, Lenkiewicz Elizabeth, Malasi Smriti, Andreozzi Mariacarla, McCullough Ann E, Anderson Karen S, Pockaj Barbara A, Wilson Melissa A, Barrett Michael |
| Use of Circulating Tumor DNA for the Clinical Management of Metastatic Castration-Resistant Prostate Cancer: A Multicenter, Real-World Study. Journal of the National Comprehensive Cancer Network : JNCCN 2021 5 19 (8): 905-914. Dong Baijun, Fan Liancheng, Yang Bin, Chen Wei, Li Yonghong, Wu Kaijie, Zhang Fengbo, Dong Haiying, Cheng Huihua, Pan Jiahua, Zhu Yinjie, Chi Chenfei, Dong Liang, Sha Jianjun, Li Lei, Yao Xudong, Xue W |
| Safety and efficacy of veliparib plus carboplatin/paclitaxel in patients with HER2-negative metastatic or locally advanced breast cancer: subgroup analyses by germline BRCA1/2 mutations and hormone receptor status from the phase-3 BROCADE3 trial. Therapeutic advances in medical oncology 2021 12 13 17588359211059601. Ayoub Jean-Pierre, Wildiers Hans, Friedlander Michael, Arun Banu K, Han Hyo S, Puhalla Shannon, Shparyk Yaroslav, Jakobsen Erik H, Wu Meijing, Bach Bruce A, Feng Dai, Ratajczak Christine K, Maag David, Diéras Véroniq |
| Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA. OncoTargets and therapy 2022 5 15 571-584. Li Jie, Chen Siwen, Xue Hui, Wang Haoyi, Huang Tianwei, Xie Hongya, He Jiang, Ke Cai, Yu Zhaonan, Ni B |
| Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene Alterations. Current oncology (Toronto, Ont.) 2022 4 29 (4): 2776-2791. Neviere Zoé, Coquan Elodie, Brachet Pierre-Emmanuel, Meriaux Emeline, Bonnet Isabelle, Krieger Sophie, Castéra Laurent, Vaur Dominique, Boulouard Flavie, Leconte Alexandra, Lequesne Justine, Lelaidier Anais, Ricou Agathe, Joly Floren |
| Olaparib maintenance monotherapy in platinum-sensitive relapsed ovarian cancer patients without a germline BRCA1/BRCA2 mutation: OPINION primary analysis. Gynecologic oncology 2022 1 164 (3): 498-504. Poveda A, Lheureux S, Colombo N, Cibula D, Lindemann K, Weberpals J, Bjurberg M, Oaknin A, Sikorska M, González-Martín A, Madry R, Pérez M J Rubio, Ledermann J, Davidson R, Blakeley C, Bennett J, Barnicle A, Škof |
| Olaparib and celarasertib (AZD6738) in patients with triple negative advanced breast cancer: results from Cohort E of the plasmaMATCH trial (CRUK/15/010). Clinical cancer research : an official journal of the American Association for Cancer Research 2023 9 . Alistair Ring, Lucy S Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr, Andrew M Wardley, Bora Gurel, Iain R Macpherson, Ruth Riisnaes, Richard D Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C Winter, Kathryn Dunne, Ellen Copson, Tamas Hickish, Russell Burcombe, Kat Randle, Violeta Serra, Alba Llop-Guevara, Judith M Bliss, Nicholas C Turn |
| The Genomic Landscape of Colorectal Cancer in the Saudi Arabian Population Using a Comprehensive Genomic Panel. Diagnostics (Basel, Switzerland) 2023 9 13 (18): . Ebtehal Alsolme, Saleh Alqahtani, Musa Fageeh, Duna Barakeh, Nitesh K Sharma, Serghei Mangul, Heather A Robinson, Amany Fathaddin, Charlotte A E Hauser, Malak Abedalthaga |
| Metastatic lung adenocarcinoma with BRCA2 mutation and longstanding disease control on olaparib, developing triple negative breast adenocarcinoma with additional BRCA2 reversion mutation: a case report. Journal of medical case reports 2023 9 17 (1): 407. Auro Del Giglio, Beatriz da Costa Aguiar Alves, André Márcio Murad, Fernando Luiz Affonso Fonse |
| Somatic and Germline Variants Affect Prognosis and Susceptibility in Prostate Cancer. Anticancer research 2023 6 43 (7): 2941-2949. Christian Rocca, Giulia Rocca, Pietro Zampieri, Lucio Dell'atti, Nicoletta Bianchi, Carmelo Ippolito, Gianluca Aguia |
| Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2?+?metastatic breast cancer. Scientific reports 2023 6 13 (1): 9928. Kyoungmin Lee, Jongwon Lee, Jungmin Choi, Sung Hoon Sim, Jeong Eun Kim, Min Hwan Kim, Yeon Hee Park, Jee Hyun Kim, Su-Jin Koh, Kyong Hwa Park, Myoung Joo Kang, Mi Sun Ahn, Kyoung Eun Lee, Hee-Jun Kim, Hee Kyung Ahn, Han Jo Kim, Keon Uk Park, In Hae Pa |
| Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers. European journal of cancer (Oxford, England : 1990) 2023 3 185 105-118. Lozano Rebeca, Castro Elena, Lopez-Campos Fernando, Thorne Heather, Ramirez-Backhaus Miguel, Aragon Isabel M, Cendón-Florez Ylenia, Gutierrez-Pecharroman Ana, Salles Daniela C, Romero-Laorden Nuria, Lorente David, González-Peramato Pilar, Calatrava Ana, Alonso Concepción, Anido Urbano, Arévalo-Lobera Sara, Balmaña Judith, Chirivella Isabel, Juan-Fita María José, Llort Gemma, Y Cajal Teresa Ramón, Almagro Elena, Alameda Daniel, López-Casas Pedro P, Herrera Bernardo, Mateo Joaquin, Pritchard Colin C, Antonarakis Emmanuel S, Lotan Tamara L, Rubio-Briones José, Sandhu Shahneen, Olmos Dav |
| Serial circulating-tumor DNA analysis with a tumor naïve next-generation sequencing panel detects minimal residual disease and predicts outcome in ovarian cancer. Cancer research 2023 12 . Jinho Heo, Yoo-Na Kim, Saeam Shin, Kyunglim Lee, Ji-Hyun Lee, Yong Jae Lee, Zisun Choi, Jihyang Park, Seungki Min, Sang Wun Kim, Jong Rak Choi, Sunghoon Kim, Seung-Tae Lee, Jung-Yun L |
| Olaparib for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer and Alterations in BRCA1 and/or BRCA2 in the PROfound Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2023 11 JCO2300339. Joaquin Mateo, Johann S de Bono, Karim Fizazi, Fred Saad, Neal Shore, Shahneen Sandhu, Kim N Chi, Neeraj Agarwal, David Olmos, Antoine Thiery-Vuillemin, Mustafa Özgüro?lu, Niven Mehra, Nobuaki Matsubara, Jae Young Joung, Charles Padua, Ernesto Korbenfeld, Jinyu Kang, Helen Marshall, Zhongwu Lai, Alan Barnicle, Christian Poehlein, Natalia Lukashchuk, Maha Hussa |
| Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study. ESMO open 2023 10 8 (6): 102041. S Joris, H Denys, J Collignon, M Rasschaert, D T'Kint de Roodenbeke, F P Duhoux, J-L Canon, S Tejpar, J Mebis, L Decoster, P Aftimos, J De Grè |
| Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancer. BMC cancer 2024 8 24 (1): 1000. Yasuharu Kawamoto, Takuo Yamai, Kenji Ikezawa, Yusuke Seiki, Ko Watsuji, Takeru Hirao, Makiko Urabe, Yugo Kai, Ryoji Takada, Kaori Mukai, Tasuku Nakabori, Hiroyuki Uehara, Tazuko Inoue, Fumie Fujisawa, Kazuyoshi Ohka |
| BRCA1, BRCA2 and PALB2 mRNA Expression as Prognostic Markers in Patients with Early Breast Cancer. Biomedicines 2024 6 12 (6): . Ina Shehaj, Slavomir Krajnak, Katrin Almstedt, Yaman Degirmenci, Sophia Herzog, Antje Lebrecht, Valerie Catherine Linz, Roxana Schwab, Kathrin Stewen, Walburgis Brenner, Annette Hasenburg, Marcus Schmidt, Anne-Sophie Heim |
- Page last reviewed:Feb 1, 2024
- Content source: